Concomitant Genetic Alterations With Response to Treatment and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR-Mutant Advanced Non-Small Cell Lung Cancer

被引:141
|
作者
Hong, Shaodong [1 ,2 ,3 ]
Gao, Fangfang [1 ,2 ,3 ]
Fu, Sha [4 ]
Wang, Yan [5 ]
Fang, Wenfeng [1 ,2 ,3 ]
Huang, Yan [1 ,2 ,3 ]
Zhang, Li [1 ,2 ,3 ]
机构
[1] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[2] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, 651 Dongfeng East Rd, Guangzhou 510060, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Dept Pathol, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China
[5] Quest Genom, Nanjing, Jiangsu, Peoples R China
基金
国家重点研发计划;
关键词
CHEMOTHERAPY; METAANALYSIS; IMPACT;
D O I
10.1001/jamaoncol.2018.0049
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
下载
收藏
页码:739 / 742
页数:5
相关论文
共 50 条
  • [31] Treatment of brain metastases in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations: the role of EGFR tyrosine kinase inhibitors
    Karachaliou, Niki
    Rosell, Rafael
    ANNALS OF PALLIATIVE MEDICINE, 2013, 2 (03) : 114 - 117
  • [32] Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    周清
    魏雪武
    高欣
    何韵婷
    杨潇蓉
    Science Foundation in China, 2019, 27 (01) : 72 - 80
  • [33] Epidermal growth factor receptor tyrosine kinase inhibitors - Application in non-small cell lung cancer
    Thomas, M
    CANCER NURSING, 2003, 26 (06) : 21S - 25S
  • [34] Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
    Hammerman, Peter S.
    Jaenne, Pasi A.
    Johnson, Bruce E.
    CLINICAL CANCER RESEARCH, 2009, 15 (24) : 7502 - 7509
  • [35] Plasma ctDNA monitoring during epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor treatment in patients with EGFR-mutant non-small cell lung cancer (JP-CLEAR trial)
    Usui, Kazuhiro
    Yokoyama, Takuma
    Naka, Go
    Ishida, Hiroo
    Kishi, Kazuma
    Uemura, Kohei
    Ohashi, Yasuo
    Kunitoh, Hideo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (06) : 554 - 558
  • [36] Advanced non-Small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitors
    Chen, Yu-Mu
    Lai, Chien-Hao
    Rau, Kun-Ming
    Huang, Cheng-Hua
    Chang, Huang-Chih
    Chao, Tung-Ying
    Tseng, Chia-Cheng
    Fang, Wen-Feng
    Chen, Yung-Che
    Chung, Yu-Hsiu
    Wang, Yi-Hsi
    Su, Mao-Chang
    Huang, Kuo-Tung
    Liu, Shih-Feng
    Chen, Hung-Chen
    Chang, Ya-Chun
    Chang, Yu-Ping
    Wang, Chin-Chou
    Lin, Meng-Chih
    LUNG CANCER, 2016, 98 : 99 - 105
  • [37] Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors for Treatment of Malignant Pleural Effusion in EGFR-Mutant Lung Adenocarcinoma Patients
    Lee, K.
    Chung, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [38] Epidermal growth factor receptor tyrosine kinase inhibitors with conventional chemotherapy for the treatment of non-small cell lung cancer
    Gao, Yuan
    Song, PingPing
    Li, Hui
    Guo, HongBo
    Jia, Hui
    Zhang, BaiJiang
    ONCOTARGETS AND THERAPY, 2016, 9 : 13 - 20
  • [39] Adjuvant EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: still an investigational approach
    Jassem, Jacek
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S387 - S390
  • [40] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Non-Small Cell Lung Cancer With Uncommon Mutations
    Kanazu, Masaki
    Naoki, Yoko
    Shiroyama, Takayuki
    Tamiya, Motohiro
    Tamiya, Akihiro
    Omachi, Naoki
    Okishio, Kyoichi
    Suzuki, Hidekazu
    Okamoto, Norio
    Morishita, Naoko
    Hirashima, Tomonori
    Atagi, Shinji
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S318 - S318